8-K/A: Terra Innovatum Global Finalizes Merger, Reports Pro Forma Loss

Terra Innovatum Global N.V. (formerly XIT Corp.) finalized its business combination, reporting pro forma net losses for the nine months ended September 30, 2025, and the year ended December 31, 2024, alongside significant contingent share structures.

Summary

• The filing is an amendment (Form 8-K/A) to a Current Report on Form 8-K, originally filed on October 16, 2025, for an event dated October 9, 2025.
• The amendment solely includes the unaudited financial statements of XIT Corp. (formerly GSR III Acquisition Corp.) as of and for the three and nine months ended September 30, 2025, and updated unaudited pro forma condensed combined financial statements.
• The business combination between GSR III Acquisition Corp. and Terra Innovatum s.r.l. was consummated on October 9, 2025, with XIT Corp. becoming a wholly-owned subsidiary of Terra Innovatum Global N.V. (PubCo).
• XIT Corp. reported a net income of $384,973 for the three months ended September 30, 2025, and $3,450,823 for the nine months ended September 30, 2025, primarily due to interest and dividends earned on investments held in its trust account.
• The pro forma condensed combined financial information for the newly formed PubCo (Terra Innovatum Global N.V.) shows a net loss of $(17,138,292) for the nine months ended September 30, 2025, and $(6,154,000) for the year ended December 31, 2024.
• A Private Investment in Public Equity (PIPE) financing was completed in September and October 2025, raising $36.8 million in gross proceeds through the issuance of PubCo Ordinary Shares and associated warrants.
• Significant portions of equity, including 8,040 PubCo Preferred Shares for former Terra Innovatum Global Quotaholders and PAC, and 549,500 Sponsor shares, are subject to vesting and conversion based on future share price performance (VWAP targets of $12, $14, $16, $18) or specific project milestones related to the SOLO Test Reactor.
• At closing, 14,475,606 Class A ordinary shares were redeemed for approximately $150.4 million, leaving approximately $88.5 million in the trust account, of which $69.8 million was transferred to Terra Innovatum Global and $18.7 million settled transaction costs.
• Former Terra Innovatum Global Quotaholders hold approximately 67.6% of the total voting rights in PubCo at the Closing, with 47,500,000 PubCo Ordinary Shares issued to them.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. The successful completion of a complex business combination and a significant PIPE financing are strong positives, alleviating prior going concern doubts. However, the initial pro forma net losses for the combined entity and the highly contingent nature of a substantial portion of the equity (preferred shares, sponsor shares, warrants) introduce considerable uncertainty and potential dilution, tempering overall enthusiasm until operational performance and milestone achievements become clearer.

Positives

• The business combination between GSR III Acquisition Corp. and Terra Innovatum s.r.l. was successfully consummated on October 9, 2025, forming Terra Innovatum Global N.V. (PubCo).
• The completion of the business combination alleviated substantial doubt about XIT Corp.'s (formerly GSR III) ability to continue as a going concern.
• XIT Corp. generated significant interest and dividends from its trust account, leading to a net income of $384,973 for the three months and $3,450,823 for the nine months ended September 30, 2025.
• A PIPE financing successfully raised $36.8 million in gross proceeds, providing additional capital for the combined entity.
• The combined entity met the minimum net tangible asset requirement of $5,000,001 and the available cash requirement of $25.0 million at closing.

Negatives

• The pro forma condensed combined financial statements show a net loss of $(17,138,292) for the nine months ended September 30, 2025, and $(6,154,000) for the year ended December 31, 2024, for the combined entity (PubCo).
• XIT Corp.'s general and administrative expenses significantly increased to $2,083,496 for the three months and $3,878,833 for the nine months ended September 30, 2025, compared to prior periods.
• XIT Corp.'s accumulated deficit worsened to $(11,193,059) as of September 30, 2025, from $(7,314,268) at December 31, 2024.
• A significant portion of the equity (PubCo Preferred Shares and Sponsor shares) is contingently convertible or subject to forfeiture based on future share price performance or project milestones, introducing uncertainty for these shareholders.

Risks

• The impact of significant global events such as the Russia/Ukraine and Israel/Palestine conflicts on the Company's financial position, results of operations, and search for a target company is not readily determinable.
• A substantial portion of PubCo Preferred Shares and Sponsor shares are subject to vesting or forfeiture conditions tied to future PubCo Trading Price milestones ($12.00, $14.00, $16.00, $18.00) or the achievement of specific project milestones (e.g., NRC docketing, construction permits, operating license for SOLO Test Reactor) within defined periods (5 or 7 years), posing a risk of non-conversion or forfeiture.
• The fair value of certain equity-linked instruments (contingent shares and warrants) is subject to significant estimation and market volatility, which could impact the Company's financial statements.
• The Company's ability to achieve the required share price triggers or project milestones for the conversion of contingent shares is uncertain and depends on future operational and market performance.

Future Outlook

The future outlook for Terra Innovatum Global N.V. is heavily tied to the achievement of specific operational and market milestones. A significant portion of equity, including PubCo Preferred Shares and Sponsor shares, is contingently convertible or subject to forfeiture based on future share price performance (VWAP targets of $12.00, $14.00, $16.00, $18.00) or the successful completion of project milestones. These milestones include the submittal and docketing of planned Pre-Application Topical Reports, NRC docketing of the SOLO Construction Permit Application, acceptance and docketing of the SOLO Test Reactor Construction Permit, and the issuance of an operating license for the SOLO Test Reactor, all within specified five-to-seven-year periods. The company's ability to meet these targets will determine the full equity structure and value for certain stakeholders.

Industry Context

The completion of this business combination reflects the ongoing trend of Special Purpose Acquisition Companies (SPACs) merging with private operating companies to go public. Terra Innovatum Global N.V.'s focus on the SOLO Test Reactor and related regulatory milestones suggests its operations are within the nuclear energy sector, which is experiencing renewed interest for its role in clean energy and advanced reactor development. The complex contingent share structures tied to operational and market performance are a common feature in SPAC transactions designed to align incentives and provide earn-out potential for pre-combination shareholders and sponsors.

Corporate Governance

Related Party Transactions

• The Sponsor paid $25,000 for 5,750,000 Class B ordinary shares (Founder Shares) of GSR III Acquisition Corp.
• The Sponsor transferred 30,000 Founder Shares to three independent directors and 225,000 Founder Shares to a member of the management team at a nominal price.
• GSR III entered into an Administrative Services Agreement with the Sponsor, agreeing to pay up to $55,556 per month for office space and administrative services. $166,668 and $500,004 were incurred for the three and nine months ended September 30, 2025, respectively.
• The Sponsor loaned GSR III up to $300,000 via a promissory note in June 2024, which was repaid by November 8, 2024.
• The Sponsor, members of the founding team, or their affiliates may provide Working Capital Loans to finance transaction costs, convertible into private placement units, though no such loans were outstanding as of September 30, 2025.

Stakeholder Impact

• **Shareholders (GSR III Public)**: Experienced redemptions of 14,475,606 shares for approximately $150.4 million, while non-redeeming shareholders received PubCo Ordinary Shares on a one-for-one basis.
• **Shareholders (Terra Innovatum Global Quotaholders)**: Received 47,500,000 PubCo Ordinary Shares and 8,000 PubCo Preferred Shares, with the latter subject to contingent conversion based on future performance and project milestones.
• **Sponsor**: Holds 5,495,000 PubCo Ordinary Shares, with 549,500 of these subject to vesting or forfeiture based on the same contingent milestones as the preferred shares, aligning their long-term interests with company performance.
• **PIPE Investors**: Provided $36.8 million in capital in exchange for PubCo Ordinary Shares and warrants, becoming new stakeholders in the combined entity.
• **Financial Advisors (PAC/Moonshot)**: Received a $2.5 million cash success fee, 223,000 PubCo Ordinary Shares, a warrant for 1,000,000 PubCo Ordinary Shares, and 40 PubCo Preferred Shares (contingent), indicating significant compensation for their role in the transaction.
• **Creditors (Bridge Loan Lenders)**: Their loans were converted into 851,483 PubCo Ordinary Shares at closing, effectively converting debt to equity.

Next Steps

• Achieve volume weighted average price (VWAP) targets of $12.00, $14.00, $16.00, and $18.00 for PubCo Ordinary Shares within specified five-to-seven-year periods to trigger conversion of contingent preferred and sponsor shares.
• Submittal and docketing of at least 10 planned Pre-Application Topical Reports following NEI Guidance.
• NRC docketing of the SOLO Construction Permit Application, pursuant to 10 CFR Part 50.
• Acceptance and docketing of SOLO Test Reactor Construction Permit in compliance with the requirements of the Atomic Energy Act of 1954 as set forth in 10 CFR.
• Issuance of an operating license of SOLO Test Reactor pursuant to 10 CFR Part 50.
• Repay the second $1.3 million premium payment for the prepaid directors and officers insurance policy, due six months after closing.

Key Dates

Recommendation

The completion of the business combination and the successful PIPE financing are positive developments, providing the combined entity with a public listing and capital. However, the pro forma net losses for the combined entity and the complex, highly contingent nature of a significant portion of the equity (preferred shares, sponsor shares, and warrants) introduce substantial uncertainty. The value realization for many stakeholders is dependent on achieving ambitious share price targets and specific project milestones related to the SOLO Test Reactor, which are inherently risky and long-term. A 'hold' recommendation is prudent for a seasoned investor, awaiting clearer operational performance, progress on key milestones, and a more stable equity structure before making a more definitive investment decision.

Keywords

SPAC, Business Combination, Merger, Terra Innovatum Global, XIT Corp, GSR III Acquisition Corp, Financial Statements, Pro Forma, PIPE Financing, Contingent Shares, Corporate Governance, SEC Filing, Nuclear Energy, Test Reactor